pivotal trial - Robuta Search

https://www.medtechdive.com/news/BSX-boston-scientific-pulsed-field-ablation-trial/690723/ Boston Scientific’s pivotal pulsed field ablation trial expected to succeed: analysts | MedTech Dive Positive results could position Boston Scientific to win U.S. approval for Farapulse in the second half of next year. pulsed field ablation medtech dive boston pivotal trial https://hellobanten.com/supira-medical-mengumumkan-izin-fda-atas-support-ii-pivotal-trial-untuk-kemajuan-syok-kardiogenik-dan-penunjukan-d-keith-grossman-sebagai-anggota-dewan-direksi/ Supira Medical Mengumumkan Izin FDA Atas SUPPORT II Pivotal Trial Untuk Kemajuan Syok Kardiogenik,... Apr 8, 2026 - Pencapaian penting ini menegaskan kemajuan klinis dan memperkuat dasar komersial LOS GATOS, Calif., 9 April, 2026 /PRNewswire/ — Supira Medical, Inc. (Supira)... pivotal trial syok kardiogenik medical izin fda https://www.drugdeliverybusiness.com/novocure-launches-pivotal-ovarian-cancer-trial/ Novocure launches pivotal ovarian cancer trial - Drug Delivery Business Mar 22, 2019 - Novocure launches pivotal ovarian cancer trial - Drug Delivery Business ovarian cancer drug delivery launches pivotal trial https://ulasannews.com/supira-medical-mengumumkan-izin-fda-atas-support-ii-pivotal-trial-untuk-kemajuan-syok-kardiogenik-dan-penunjukan-d-keith-grossman-sebagai-anggota-dewan-direksi/ Supira Medical Mengumumkan Izin FDA Atas SUPPORT II Pivotal Trial Untuk Kemajuan Syok Kardiogenik,... Apr 8, 2026 - Pencapaian penting ini menegaskan kemajuan klinis dan memperkuat dasar komersial LOS GATOS, Calif., 9 April, 2026 /PRNewswire/ — Supira Medical, Inc. (Supira)... pivotal trial syok kardiogenik medical izin fda https://www.fintechworldpost.com/article/946650220-orchestra-biomed-exceeds-full-enrollment-target-in-the-backbeat-global-pivotal-trial-of-avim-therapy Orchestra BioMed Exceeds Full Enrollment Target in the BACKBEAT Global Pivotal Trial of AVIM... in the pivotal trial orchestra biomed exceeds https://www.businesswire.com/news/home/20260529816966/en/Exelixis-Announces-Results-from-Subgroup-Analysis-of-Phase-3-CABINET-Pivotal-Trial-Evaluating-CABOMETYX-cabozantinib-in-Non-Functional-and-Functional-Neuroendocrine-Tumors-at-ASCO-2026 Exelixis Announces Results from Subgroup Analysis of Phase 3 CABINET Pivotal Trial Evaluating... Exelixis, Inc. (Nasdaq: EXEL) today announced results from a subgroup analysis of the phase 3 CABINET pivotal trial, which showed that CABOMETYX® (cabozantin... subgroup analysis pivotal trial exelixis announces results https://opci.live/opci-lives/primary-results-from-the-triscend-ii-pivotal-trial-with-rebecca-hahn/ Primary Results from the TRISCEND II Pivotal Trial with Rebecca Hahn - OPCI Severe tricuspid regurgitation (TR) often causes substantial impairment in patient-reported health status (ie, symptoms, physical and social function, and... from the pivotal trial primary results rebecca https://ir.opusgtx.com/press-releases/detail/499/opus-genetics-doses-first-patient-in-pivotal-lynx-3-phase-3-trial-evaluating-phentolamine-ophthalmic-solution-0-75-in-keratorefractive-patients-with-visual-disturbances-under-mesopic-low-contrast-conditions Opus Genetics Doses First Patient in Pivotal LYNX-3 Phase 3 Trial Evaluating Phentolamine... September 04, 2025 8:00am EDT - RESEARCH TRIANGLE PARK, N.C., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Opus Genetics, Inc. (Nasdaq: IRD), a clinical-stage... opus genetics doses first patient https://www.hungarianindustrymonitor.com/article/944244541-maia-biotechnology-reports-pivotal-phase-3-clinical-trial-progress-in-advanced-non-small-cell-lung-cancer MAIA Biotechnology Reports Pivotal Phase 3 Clinical Trial Progress in Advanced Non-Small Cell Lung... Hungarian Industry Monitor is an online news publication focusing on industries in the Hungary: The latest industries and services news from Hungary maia biotechnology clinical trial small cell reports pivotal https://biopharmajournal.com/2021/07/06/citius-pharmaceuticals-inc-nasdaq-ctxr-to-continue-phase-3-pivotal-superiority-trial-after-idmc-did-not-observe-any-safety-concerns/ Citius Pharmaceuticals Inc (NASDAQ: CTXR) To Continue Phase 3 Pivotal Superiority Trial after IDMC... Jul 6, 2021 - News Alert: Citius Pharmaceuticals Receives FDA Approval For LYMPHIR™ (Denileukin Diftitox-Cxdl) Immunotherapy For The Treatment Of Adults With Relapsed Or... to continue superiority trial citius pharmaceuticals inc https://www.propharmagroup.com/thought-leadership/fda-default-drug-approval-requirements-one-pivotal-trial-regulatory-strategy-implications FDA's Shift to One Pivotal Trial for Drug Approval: Strategic Implications for Sponsors FDA’s shift to one pivotal trial raises global stakes. Learn how to engineer globally acceptable development programs from the start. pivotal trial drug approval fda shift one https://www.optometrytimes.com/view/first-patient-enrolled-in-ocuphire-phase-3-pivotal-trial-of-nyxol-for-presbyopia First patient enrolled in Ocuphire Phase 3 pivotal trial of Nyxol for presbyopia | Optometry Times... Oct 10, 2026 - The VEGA-2 pivotal trial is investigating Nyxol alone and Nyxol with adjunctive low-dose pilocarpine therapy for the treatment of presbyopia. pivotal trial first patient enrolled phase https://www.brai3n.com/onderzoeksprojecten/tent-a3-controlled-pivotal-clinical-trial-combining-sound-and-tongue-stimulation-for-the-treatment-of-tinnitus TENT-A3: Controlled Pivotal Clinical Trial: Combining Sound and Tongue Stimulation for the... TENT-A3 onderzoekt de effectiviteit van bimodale neuromodulatie — een combinatie van geluid en tongstimulatie — als behandeling voor matige tot ernstige... clinical trial for the tent controlled pivotal https://www.newproductsdigest.com/article/946650220-orchestra-biomed-exceeds-full-enrollment-target-in-the-backbeat-global-pivotal-trial-of-avim-therapy Orchestra BioMed Exceeds Full Enrollment Target in the BACKBEAT Global Pivotal Trial of AVIM... New Products Digest is an online news publication focusing on consumer goods: Your top news on consumer products in the pivotal trial orchestra biomed exceeds https://retinalphysician.com/issues/2026/clinical-trials-at-the-summit/cts-lensone/ LensOne Heads Toward Pivotal Trial | Retinal Physician pivotal trial heads toward retinal physician https://tworiver.com/news-posts/allogene-therapeutics-initiates-pivotal-phase-2-trial-investigating-cemacabtagene-ansegedleucel-cema-cel-an-allogeneic-car-t-product-as-part-of-first-line-treatment-for-patients-with-large-b-cell/ Allogene Therapeutics Initiates Pivotal Phase 2 Trial Investigating Cemacabtagene Ansegedleucel... allogene therapeutics initiates pivotal phase trial https://www.newschannelaustralia.com/article/943888548-beacon-therapeutics-reports-positive-topline-data-from-the-pivotal-vista-trial-of-laru-zova-for-the-treatment-of-x-linked-retinitis-pigmentosa-xlrp Beacon Therapeutics Reports Positive Topline Data from the Pivotal VISTA Trial of Laru-zova for the... News Channel Australia is an online news publication focusing on the Australia: The most trusted news from Australia from the beacon therapeutics reports positive https://salesandmarketingnetwork.com/news_release_bs.html?pipe=0000ac177000191&ID=2015799&key=AIMM News for Medical Sales Reps: Vical Initiates Pivotal Phase 3 Trial of Allovectin-7(R) as First-line... sales reps first line news medical initiates https://www.medtechdive.com/news/corvia-atrial-shunt-fails-heart-failure-trial/618148/ Edwards-backed Corvia fails pivotal heart failure trial but clings to subgroup efficacy signal |... Corvia Medical's atrial shunt therapy has failed to improve cardiovascular disease outcomes in heart failure patients, according to clinical trial results. heart failure clings to edwards backed corvia https://www.healthprofessionaltimes.com/article/943027155-sol-gel-technologies-announces-last-patient-last-visit-in-pivotal-phase-3-clinical-trial-of-sgt-610-in-gorlin-syndrome Sol-Gel Technologies Announces Last Patient Last Visit in Pivotal Phase 3 Clinical Trial of SGT-610... sol gel last patient clinical trial technologies announces https://www.louisianaindustryjournal.com/article/943888548-beacon-therapeutics-reports-positive-topline-data-from-the-pivotal-vista-trial-of-laru-zova-for-the-treatment-of-x-linked-retinitis-pigmentosa-xlrp Beacon Therapeutics Reports Positive Topline Data from the Pivotal VISTA Trial of Laru-zova for the... Louisiana Industry Journal is an online news publication focusing on industries in the Louisiana: Reporting on industries and services news in Louisiana from the beacon therapeutics reports positive https://www.francismedical.com/francis-medical-announces-publication-of-vapor-2-pivotal-trial-results-in-the-journal-of-urology/ Francis Medical Announces Publication of VAPOR 2 Pivotal Trial Results in The Journal of Urology -... Jul 2, 2026 - MAPLE GROVE, Minn., June 30, 2026 – Francis Medical, Inc., a medical device company dedicated to advancing minimally invasive therapies for urological cancers,... pivotal trial results in the journal francis medical https://www.potomachealthnews.com/article/946650220-orchestra-biomed-exceeds-full-enrollment-target-in-the-backbeat-global-pivotal-trial-of-avim-therapy Orchestra BioMed Exceeds Full Enrollment Target in the BACKBEAT Global Pivotal Trial of AVIM... in the pivotal trial orchestra biomed exceeds https://ncaep.fpg.unc.edu/resource/a-randomized-clinical-trial-comparison-between-pivotal-response-treatment-prt-and-adult-driven-applied-behavior-analysis-aba-intervention-on-disruptive-behaviors-in-public-school-children-with-aut/ A Randomized Clinical Trial Comparison Between Pivotal Response Treatment (PRT) and Adult-Driven... randomized clinical trial pivotal response treatment comparison prt adult https://www.eyefox.com/news/3032/x-linked-retinitis-pigmentosa-positive-topline-data-from-the-pivotal-vista-trial X-linked Retinitis Pigmentosa: Positive Topline Data from the Pivotal VISTA Trial Beacon Therapeutics announced positive topline results for its registration-enabling VISTA trial evaluating laruparetigene zovaparvovec (laru-zova) in patients... x linked retinitis pigmentosa from the positive topline